Replies to post #148 on Diadexus Inc. (fka DDXSQ)

[Planopenny]

Did you see this? They never released that news. Interesting
South San Francisco, CA – June 29, 2011 – diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today announced that it expects to report strong revenue growth for the 2011 second quarter with revenues of $3.8 million, a 45% increase over the comparable 2010 quarter.

What's up with this? I wonder if he was just there to get them off the ground and now moving onto the next one? Just guessing
On June 29, 2011, diaDexus, Inc. (the “Company”) announced that Patrick Plewman resigned as President and Chief Executive Officer and as a director of the Company effective as of July 1, 2011. Mr. Plewman will serve as a consultant to the Company for an eighteen-month period ending on January 1, 2013. The Company’s Board of Directors has appointed director James P. Panek to serve as interim President and Chief Executive Officer of the Company effective July 1, 2011. The Board of Directors has also appointed director Brian E. Ward, Ph.D. to serve as interim Chief Operating Officer also effective July 1, 2011. Compensation terms for Mr. Panek and Dr. Ward for service in their interim roles have not yet been determined.